Not All Microneedling Is the Same

By Lynn Adami BSN RN-BC — New Skin by Lynn, San Mateo

​

Microneedling has become one of the most searched skin rejuvenation treatments of the past decade — and with that popularity has come a proliferation of devices, settings, and providers offering what they all call microneedling. A $30 dermaroller from an online retailer. A $1000 consumer pen marketed for home use. A treatment at a nail salon or day spa. A session at a medical aesthetics practice under physician direction. They share a name. They share very little else. At New Skin by Lynn in San Mateo Lynn Adami BSN RN-BC performs medical microneedling using FDA-approved clinical devices — and the clinical difference between what happens in that treatment room and what happens at home or in a non-clinical setting is not a matter of degree. It is a matter of kind.

​

WHAT MICRONEEDLING ACTUALLY DOES — AND WHY DEPTH MATTERS

Understanding why not all microneedling is the same begins with understanding what microneedling is actually trying to accomplish biologically. The goal of a clinical microneedling session is not simply to puncture the skin — it is to reach the dermis. The dermis is the deeper structural layer of the skin where fibroblast cells live — the cells responsible for producing collagen and elastin. When the dermis is reached with controlled precision the skin initiates a genuine wound-healing cascade — recruiting fibroblasts to produce new collagen and elastin and triggering a biological repair response that progressively improves skin structure, texture, and quality over the following weeks.

Clinical research confirms that reaching dermal depth — typically between 0.5mm and 2.5mm depending on the area and concern being treated — is what separates a treatment that produces genuine structural results from one that simply improves the absorption of topical products. Deep structural concerns — atrophic acne scars, pronounced wrinkles, significant skin laxity — require dermal penetration to respond to microneedling. Surface-level penetration cannot reach the cells responsible for structural repair.

This single fact — depth — is the foundation on which every meaningful distinction between microneedling devices and settings rests.

​

HOME DEVICES — WHAT THEY CAN AND CANNOT DO

The consumer microneedling market has expanded dramatically — from manual dermarollers costing a few dollars to motorized pens marketed as professional-grade for home use. Even established medical device manufacturers have introduced consumer versions of their clinical devices — DP Derm offers the Dermapen HOME at approximately $1000, while the clinical Dermapen 4 used in professional settings costs approximately $6000. The price difference reflects a fundamental difference in engineering and capability — not simply branding.

Consumer devices — whether manual dermarollers, stamps, or motorized consumer pens — are legally restricted or designed to penetrate only the outermost skin layer — the epidermis — at depths of 0.25mm or less. At this depth consumer devices can modestly improve the absorption of topical serums and produce temporary surface brightening. They cannot reach the dermis. They cannot trigger the fibroblast-driven collagen and elastin production that produces genuine structural improvement. For surface-level maintenance and serum absorption enhancement a responsibly used quality consumer device may offer modest benefits. For true anti-aging results, skin tightening, or scar revision — clinical data consistently shows that consumer-grade devices do not possess the depth, mechanical precision, or safety engineering required.

Beyond depth — the mechanical action of consumer devices introduces specific risks that clinical devices are engineered to eliminate:

Micro-tearing — manual dermarollers enter and exit the skin at an angle as the wheel rotates rather than at the strict 90-degree vertical angle of clinical motorized pens. This angled action causes micro-tearing and slicing of the epidermis rather than clean vertical micro-channels — increasing inflammation, extending downtime, and potentially worsening skin texture or triggering hyperpigmentation.

Needle quality — consumer devices frequently use lower-grade metals that dull or bend with use. Even microscopic bending at a needle tip causes epidermal scratching rather than clean micro-channel creation. FDA-approved medical devices use surgical-grade regulated materials with single-use sterile cartridges discarded after each session.

Cross-contamination risk — professional FDA-approved microneedling cartridges feature sealed fluid barriers that prevent blood and tissue fluid from being drawn back into the device mechanism during treatment. Many consumer motorized pens lack this anti-backflow protection — meaning fluid from a previous session can remain trapped in the motor housing creating a serious biohazard risk for subsequent use. Combined with the common practice of reusing consumer needle cartridges — which cannot be adequately sterilized at home — documented cases of persistent staph infections, granulomas, and scarring have been associated with unsupervised consumer device use.

​

NON-CLINICAL SETTINGS — WHY THE PROVIDER AND ENVIRONMENT MATTER

The distinction between home and clinical microneedling extends beyond the device itself to the setting in which treatment is performed and the credentials of the person performing it. Microneedling is offered in a wide range of settings — day spas, nail salons, beauty studios, and non-medical aesthetics practices — where the devices used and the depth of treatment may be significantly limited by state regulation and the provider's scope of practice.

In California medical microneedling — performed at dermal depths that trigger a genuine wound-healing response — is a medical procedure requiring physician oversight and appropriately credentialed clinical providers. New Skin by Lynn operates under physician medical direction as required by California law — meaning every microneedling session performed by Lynn Adami BSN RN-BC is conducted within a medically supervised framework with the clinical depth and treatment customization that genuine results require.

Beyond regulation — the clinical assessment that precedes treatment matters enormously. Skin type, Fitzpatrick classification, active skin conditions, medication history, and the specific concerns being addressed all influence how a microneedling session should be designed — needle depth, pass technique, treatment interval, and adjunct treatments. This individualized clinical assessment is what a qualified medical aesthetics provider brings to every session — and what a non-clinical setting fundamentally cannot replicate.

​

WHAT MEDICAL MICRONEEDLING AT NEW SKIN BY LYNN DELIVERS

The Dermapen 4 — one of two clinical microneedling devices used at New Skin by Lynn — operates at high speed driving needles into the skin at a strict 90-degree angle. This creates clean vertical micro-channels that heal rapidly with minimal surface trauma — triggering the controlled wound-healing cascade that drives genuine collagen and elastin production. The 1Need Pro — the second clinical device in use at New Skin by Lynn — offers complementary precision for specific treatment applications.

Every microneedling session at New Skin by Lynn begins with a thorough skin assessment and consultation — establishing the appropriate treatment parameters for that client's skin type, concerns, and goals. Treatment depth, technique, and any adjunct enhancements including V-Hacker exosome therapy are selected based on clinical judgment rather than a standard protocol applied uniformly regardless of what the individual skin requires.

The result is a treatment that looks like microneedling — but delivers at a level that consumer devices and non-clinical settings simply cannot access.

​

HOW TO EVALUATE ANY MICRONEEDLING PROVIDER

For clients researching microneedling providers the following questions help distinguish clinical from non-clinical offerings:

• What device is used — is it FDA-approved for medical microneedling?

• What credentials does the provider hold — and are they operating under physician direction?

• What needle depths are used — and are they appropriate for the concerns being treated?

• Are single-use sterile cartridges used and discarded after each session?

• Is a clinical skin assessment performed before treatment parameters are established?

• Is the treatment environment medically supervised and compliant with California law?

​

LYNN'S CLINICAL PERSPECTIVE

"I see clients regularly who have tried home dermarollers or consumer pens and been disappointed — not because microneedling does not work but because what they experienced was not clinical microneedling. The depth they reached, the device they used, and the absence of clinical assessment all meant the treatment could not deliver what they were hoping for. The difference between a $30 dermaroller and a clinical Dermapen 4 session under physician direction is not a marketing distinction — it is a biological one. The skin's repair response requires dermal penetration, clean micro-channel creation, and a clinical environment where the treatment can be precisely calibrated to what that individual skin actually needs. That is what medical microneedling at New Skin by Lynn provides — and the results consistently reflect it."

— Lynn Adami BSN RN-BC, New Skin by Lynn

​

BOOK A CONSULTATION

Interested in medical microneedling at New Skin by Lynn? Book a complimentary consultation with Lynn to discuss your skin concerns and whether microneedling — standard or exosome enhanced — is the right treatment for your goals. All treatments are performed under physician medical direction as required by California law.

New Skin by Lynn is located at 241 S San Mateo Dr, Ste 7, San Mateo, CA 94401 — serving clients from Burlingame, Hillsborough, Redwood City, and throughout the San Francisco Bay Area.

Phone or Text: 650-484-4404